We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 109 results
  1. Strategies for diagnosis and management of CMMRD in low-resource countries: report of a Tunisian family

    Constitutional Mismatch Repair Deficiency (CMMRD) is a rare childhood cancer predisposition syndrome, caused by biallelic pathogenic germline...

    Rania Abdelmaksoud-Dammak, Nihel Ammous-Boukhris, ... Raja Mokdad-Gargouri in Familial Cancer
    Article 30 April 2024
  2. Using comprehensive genomic and functional analyses for resolving genotype–phenotype mismatches in children with suspected CMMRD in Lebanon: an IRRDC study

    Constitutional mismatch repair deficiency (CMMRD) is an aggressive and highly penetrant cancer predisposition syndrome. Because of its variable...

    Dima Hamideh, Anirban Das, ... Raya Saab in Human Genetics
    Article 15 February 2023
  3. Diagnostic and therapeutic challenges of glioblastoma as an initial malignancy of constitutional mismatch repair deficiency (CMMRD): two case reports and a literature review

    Background

    Constitutional mismatch repair deficiency (CMMRD) results from a biallelic germline pathogenic variant in a mismatch repair (MMR) gene. The...

    Shumpei Onishi, Fumiyuki Yamasaki, ... Takao Hinoi in BMC Medical Genomics
    Article Open access 16 January 2023
  4. CMMRD caused by PMS1 mutation in a sudanese consanguineous family

    A consanguineous family of three siblings presented with different early onset pediatric cancers. Whole-exome sequencing of parents DNA revealed a...

    Reem S. Hamad, Muntaser E. Ibrahim in Hereditary Cancer in Clinical Practice
    Article Open access 15 April 2022
  5. Diagnostic challenges in a CMMRD patient with a novel mutation in the PMS2 gene: a case report

    Background

    Constitutional mismatch repair deficiency (CMMRD) is a rare autosomal recessive condition, which is caused by biallelic mutations in...

    Shiqing Tan, **aoting Wu, ... Li Ying in BMC Medical Genomics
    Article Open access 12 July 2021
  6. Lynch syndrome: influence of additional susceptibility variants on cancer risk

    Some patients with Lynch syndrome (LS) have extreme phenotypes, i.e. cancer before the recommended screening age, or cancer for which there are no...

    Roseline Vibert, Jasmine Hasnaoui, ... Patrick R. Benusiglio in European Journal of Human Genetics
    Article 24 April 2023
  7. High amount of fertility reducing tumors and procedures, but no evidence for premature ovarian failure in female Lynch syndrome patients

    Lynch syndrome (LS; HNPCC) patients carry heterozygous pathogenic germline variants in mismatch repair (MMR) genes, which have also been shown to...

    Sabine Biermann, Michael Knapp, ... Verena Steinke-Lange in Familial Cancer
    Article Open access 27 January 2024
  8. Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma

    Background

    Lynch syndrome (LS) is not considered part of childhood cancer predisposition syndromes.

    Case presentation

    Analysis of a pediatric...

    Michaela Kuhlen, Mariola Monika Golas, ... Michael C. Frühwald in Hereditary Cancer in Clinical Practice
    Article Open access 12 June 2023
  9. A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening

    Background

    Lynch syndrome (LS) is under-diagnosed. UK National Institute for Health and Care Excellence guidelines recommend multistep molecular...

    Richard Gallon, Patricia Herrero-Belmonte, ... Michael S. Jackson in BJC Reports
    Article Open access 01 July 2024
  10. Nervous system (NS) Tumors in Cancer Predisposition Syndromes

    Genetic syndromes which develop one or more nervous system (NS) tumors as one of the manifestations can be grouped under the umbrella term of NS...

    Prabhumallikarjun Patil, Bojana Borislavova Pencheva, ... Jason Fangusaro in Neurotherapeutics
    Article 02 September 2022
  11. Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer

    Transgender and gender diverse (TGD) populations with hereditary cancer syndromes face unique obstacles to identifying and obtaining appropriate...

    Rachel Hodan, Linda Rodgers-Fouche, ... Bronwyn S. Bedrick in Familial Cancer
    Article 21 June 2023
  12. Correlation between large rearrangements and patient phenotypes in NF1 deletion syndrome: an update and review

    About 5–10% of neurofibromatosis type 1 (NF1) patients exhibit large genomic germline deletions that remove the NF1 gene and its flanking regions....

    Laurence Pacot, Milind Girish, ... Meena Upadhyaya in BMC Medical Genomics
    Article Open access 06 March 2024
  13. Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1

    Background

    Germline variants affecting the proofreading activity of polymerases epsilon and delta cause a hereditary cancer and adenomatous polyposis...

    Pilar Mur, Julen Viana-Errasti, ... Laura Valle in Genome Medicine
    Article Open access 17 October 2023
  14. Constitutional mismatch repair deficiency is the diagnosis in 0.41% of pathogenic NF1/SPRED1 variant negative children suspected of sporadic neurofibromatosis type 1

    Purpose

    Biallelic germline mismatch repair (MMR) gene pathogenic variants (PVs) cause constitutional MMR deficiency (CMMRD), a highly penetrant...

    Juan A. Perez-Valencia, Richard Gallon, ... Katharina Wimmer in Genetics in Medicine
    Article Open access 10 August 2020
  15. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

    Purpose

    By incorporating major developments in genetics, ophthalmology, dermatology, and neuroimaging, to revise the diagnostic criteria for...

    Eric Legius, Ludwine Messiaen, ... Scott R. Plotkin in Genetics in Medicine
    Article Open access 19 May 2021
  16. Heterogeneous constitutional mismatch repair deficiency with MSH6 missense mutation clinically benefits from pembrolizumab and regorafenib combination therapy: a case report and literature review

    Background

    Germline DNA mismatch repair (MMR) gene aberrations are associated with colorectal cancer (CRC) predisposition and high tumor mutation...

    Tong **e, Qin Feng, ... Zhi Peng in Hereditary Cancer in Clinical Practice
    Article Open access 09 January 2021
  17. Dominantly inherited micro-satellite instable cancer – the four Lynch syndromes - an EHTG, PLSD position statement

    The recognition of dominantly inherited micro-satellite instable (MSI) cancers caused by pathogenic variants in one of the four mismatch repair ( MMR )...

    Pal Møller, Toni T. Seppälä, ... Mev Dominguez-Valentin in Hereditary Cancer in Clinical Practice
    Article Open access 11 October 2023
  18. LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis

    Background

    Noonan syndrome (NS) is a genetic disorder characterized by developmental delays, typical facial gestalt and cardiovascular defects. LZTR1 ...

    Kirsten M. Farncombe, Emily Thain, ... Raymond H. Kim in BMC Medical Genomics
    Article Open access 15 July 2022
  19. Assessment of Microsatellite Instability from Next-Generation Sequencing Data

    Microsatellite instability (MSI) is a genetic alteration due to a deficiency of the DNA mismatch repair system, where microsatellites accumulate...
    Victor Renault, Emmanuel Tubacher, Alexandre How-Kit in Computational Methods for Precision Oncology
    Chapter 2022
Did you find what you were looking for? Share feedback.